C20ORF94 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.146000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.912400E-01
Normal-vs-Stage2
7.930000E-01
Normal-vs-Stage3
9.753600E-02
Normal-vs-Stage4
6.686400E-01
Stage1-vs-Stage2
2.541200E-01
Stage1-vs-Stage3
1.858010E-02
Stage1-vs-Stage4
9.700400E-01
Stage2-vs-Stage3
1.290840E-01
Stage2-vs-Stage4
3.296000E-01
Stage3-vs-Stage4
6.471500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.269200E-01
Normal-vs-AfricanAmerican
8.444000E-01
Normal-vs-Asian
3.784000E-01
Caucasian-vs-AfricanAmerican
5.236600E-01
Caucasian-vs-Asian
1.343810E-01
AfricanAmerican-vs-Asian
1.769370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.191600E-01
Normal-vs-Female
8.130800E-01
Male-vs-Female
8.404600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.060600E-01
Normal-vs-Age(41-60Yrs)
8.845000E-01
Normal-vs-Age(61-80Yrs)
6.508200E-01
Normal-vs-Age(81-100Yrs)
6.435400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.109600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.492400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.591200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.866300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.708400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.981000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.894800E-01
Normal-vs-Daily Drinker
2.189000E-01
Normal-vs-Weekly Drinker
5.607800E-01
Normal-vs-Occasional Drinker
8.280400E-01
Normal-vs-Social Drinker
8.002000E-01
Non Drinker-vs-Daily Drinker
2.760800E-01
Non Drinker-vs-Weekly Drinker
9.534600E-01
Non Drinker-vs-Occasional Drinker
8.169700E-02
Non Drinker-vs-Social Drinker
1.566000E-01
Daily Drinker-vs-Weekly Drinker
3.469000E-01
Daily Drinker-vs-Occasional Drinker
1.480300E-02
Daily Drinker-vs-Social Drinker
4.820100E-02
Weekly Drinker-vs-Occasional Drinker
1.883210E-01
Weekly Drinker-vs-Social Drinker
2.126800E-01
Occasional Drinker-vs-Social Drinker
8.764000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.578810E-01
Normal-vs-Grade 2
1.001840E-01
Normal-vs-Grade 3
4.039900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.422200E-01
Grade 1-vs-Grade 3
6.264200E-01
Grade 1-vs-Grade 4
1.578810E-01
Grade 2-vs-Grade 3
2.752200E-01
Grade 2-vs-Grade 4
1.001840E-01
Grade 3-vs-Grade 4
4.039900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.416600E-01
Normal-vs-NonDiabetic
7.053200E-01
Diabetic-vs-NonDiabetic
4.141200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.973190E-01
Normal-vs-NoPancreatitis
7.374600E-01
Pancreatitis-vs-NoPancreatitis
1.898440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.010600E-01
Normal-vs-N1
8.376800E-01
N0-vs-N1
7.853000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.474200E-01
Normal-vs-TP53-NonMutant
8.159000E-01
TP53-Mutant-vs-TP53-NonMutant
5.488200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
